Dividends Calendar Earnings Calendar
OVID

OVID | Ovid Therapeutics Inc

2.96 -0.5 (-14.54%) 
Ovid Therapeutics Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   United States of America

Trade prices

  • Volume:
  • Market Cap: 271.17M
  • Prev closed: 4.02
  • Open: 4.03
  • High: 4.14
  • Low: 3.97
  • 52 week low: 2.25
  • 52 week high: 9.4
  • Dividends:No Dividends

Next ER: May 11, 2021 



Top Stories (OVID)

    Company Profile

    Ovid Therapeutics Inc. is a New York-based biopharmaceutical company using its BoldMedicine® approach to develop medicines that transform the lives of patients with rare neurological disorders. Ovid has a broad pipeline of potential first-in-class medicines. The company?s most advanced investigational medicine, OV101 (gaboxadol), is currently in clinical development for the treatment of Angelman syndrome and Fragile X syndrome. Ovid is also developing soticlestat in collaboration with Takeda Pharmaceutical Company Limited for the potential treatment of rare developmental and epileptic encephalopathies (DEE).

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    August 12, 2021
    May 11, 2021- / 1.45- / -
    April 1, 2021- / -0.3099- / 4.16M
    March 15, 2021-0.34 / -0.30565.7M / 4.16MBeat!
    November 12, 2020-0.28 / -0.35046.91M / 100K
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    May 6, 2021 3.46 3.50
    3.51
    3.35
    699.65K -1.7%
    May 5, 2021 3.52 3.67
    3.67
    3.50
    622.75K -3.3%
    May 4, 2021 3.64 3.67
    3.67
    3.55
    709.02K -2.41%
    May 3, 2021 3.73 3.74
    3.76
    3.63
    606.23K 1.63%
    Apr 30, 2021 3.67 3.84
    3.90
    3.66
    864.42K -5.17%
    Apr 29, 2021 3.87 3.91
    3.93
    3.80
    481.75K -1.53%
    Apr 28, 2021 3.93 3.78
    3.97
    3.77
    486.05K 2.34%
    Apr 27, 2021 3.84 3.95
    3.97
    3.79
    498.90K -1.29%
    Apr 26, 2021 3.89 3.67
    3.94
    3.65
    714.65K 5.99%
    Apr 23, 2021 3.67 3.68
    3.76
    3.59
    863.06K 0.27%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2014
    • Employees:67

    News

    News for (OVID)

    This company doesn't provide a dividend.


    Talk about Ovid Therapeutics Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on May 11, 2021 (Same day)

    ea tm hmc vod armk hbi dar tdg ir prgo lmnd pltr 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 50
    HOLD 50
    SELL 0

    Their Official Profiles 

    TwitterLinkedInInstagramYoutube

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Swing Trading For Dummies
    Buy on Amazon

    Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.

    Take advantage of price swings in strongly trending securities and pump up your portfolio!